Leukemia Drug Gleevec Continues to Amaze

	Tweet

It was late 1997 and Doug Jensen, 71, of Canby, Ore., thought he’d developed a particularly stubborn cold. But his symptoms dragged on and “kept getting worse,” he said.

Then Jensen got the devastating news: Blood tests confirmed he had chronic myelogenous leukemia (CML), a deadly blood cancer.

In 1997, average life expectancy for CML patients “was about four to six, maybe seven years,” according to Dr. Brian Druker, a cancer researcher at Howard Hughes Medical Institute and the Oregon Health and Science University Cancer Institute, in nearby Portland.

RELATED STORIES:
U.S. FDA warns Barr over Seasonale commercial   US FDA allows tracking tags on drug bottles   Chinese drugs driving down generic prices   Expert Warns of Overuse of Over-the-Counter Pain Medication   FDA chief to meet with top lawmaker about Vioxx   Shut down Internet drug retailing, Boudria says   New Antibiotic Shortens Tuberculosis Treatment Time   Solution to Bacterial Mystery Promises New Drugs   Medical journal says Merck deleted Vioxx dangers   Pharmacokinetics of tramadol in children   Don’t compromise safety, says drug import report   Pfizer provides opinion on European Lipitor patent

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]